Peptide P5: A Potent Inhibitor of HIV-1 Infection
Author Information
Author(s): Yu Huifeng, Tudor Daniela, Alfsen Annette, Labrosse Beatrice, Clavel François, Bomsel Morgane
Primary Institution: Institut Cochin, Université Paris Descartes, CNRS
Hypothesis
Can peptide P5 derived from the membrane proximal region of HIV-1 gp41 inhibit HIV-1 infection?
Conclusion
Peptide P5 effectively inhibits HIV-1 infection and shows potential as a therapeutic agent against T20-resistant strains.
Supporting Evidence
- P5 inhibited HIV-1 envelope mediated cell-cell fusion and infection of peripheral blood mononuclear cells.
- P5 showed strong inhibitory activities against T20-resistant strains.
- The calcium-binding site in P5 is crucial for its antiviral activity.
- P5 exhibited higher helical content compared to less effective peptides.
- Peptide P1 did not inhibit HIV-1 infection, highlighting the importance of the calcium-binding site.
Takeaway
Peptide P5 is like a superhero that stops HIV from getting into cells, even when the virus tries to be sneaky and resistant to other treatments.
Methodology
The study involved structural analysis of peptides and their effects on HIV-1 mediated cell fusion and infection using various assays.
Limitations
The study does not address potential immunogenicity and half-life issues of peptide therapies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website